PBTZ169 is a new drug candicate that inhibits decaprenylphosphoryl-β-d-ribose 2′-oxidase (DprE1), more efficiently than BTZ043.
MoreSincalide is a cholecystokinetic drug administered by injection to aid in researching disorders of the gallbladder and pancreas.
MoreBEC hydrochloride 是一个竞争性的 Arginase II抑制剂,Ki=0.31 uM.
MoreOzanimod是一种新型口服的选择性鞘氨醇-1-磷酸1和5受体调节剂, 适用于自身免疫适应症。
MoreBAR501是选择性的GPBAR1激动剂(EC50=1 μM)。
MorePBTZ169 is a new drug candicate that inhibits decaprenylphosphoryl-β-d-ribose 2′-oxidase (DprE1), more efficiently than BTZ043.
MoreSincalide is a cholecystokinetic drug administered by injection to aid in researching disorders of the gallbladder and pancreas.
MoreBEC hydrochloride 是一个竞争性的 Arginase II抑制剂,Ki=0.31 uM.
MoreOzanimod是一种新型口服的选择性鞘氨醇-1-磷酸1和5受体调节剂, 适用于自身免疫适应症。
MoreBAR501是选择性的GPBAR1激动剂(EC50=1 μM)。
More